Found: 4
Select item for more details and to access through your institution.
A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 491, p. N.PAG, doi. 10.1126/scitranslmed.aat7838
- By:
- Publication type:
- Article
Aducanumab (BIIB037), an anti-amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer’s disease: Interim results of a randomized, double-blind, placebo-controlled, phase 1b study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P277, doi. 10.1016/j.jalz.2015.07.367
- By:
- Publication type:
- Article
Characterization of 3 Novel Tau Radiopharmaceuticals, <sup>11</sup>C-RO-963, <sup>11</sup>C-RO-643, and <sup>18</sup>F-RO-948, in Healthy Controls and in Alzheimer Subjects.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 12, p. 1869, doi. 10.2967/jnumed.118.209916
- By:
- Publication type:
- Article
The definition of neuronopathic Gaucher disease.
- Published in:
- Journal of Inherited Metabolic Disease, 2020, v. 43, n. 5, p. 1056, doi. 10.1002/jimd.12235
- By:
- Publication type:
- Article